FDA approval of lamotrigine expands epilepsy treatment options.
D000927:Anticonvulsants / Q000494:pharmacology; D017277:Drug Approval; D004828:Epilepsies, Partial / Q000188:drug therapy; D006801:Humans; D000077213:Lamotrigine; D014227:Triazines / Q000494:pharmacology; D014481:United States; D014486:United States Food and Drug Administration
D000927:Anticonvulsants; D014227:Triazines; D000077213:Lamotrigine